CHRS

COHERUS ONCOLOGY INC

Healthcare | Micro Cap

-$0.21

EPS Forecast

$15.19

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.21

Revenue Forecast:

$15.19

EPS Surprise Forecast:

$0.005

Revenue Surprise Forecast:

-$1

Post-release price volatility - Very high

Post-release Overnight Move:

±12.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

61%

Probability of beating revenue consensus:

33%

Probability of beating both EPS & revs consensus:

26%

Probability of missing both EPS & revs consensus:

31%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

0.77

Earnings volatility

EPS standard deviation:

$0.04

Revenue standard deviation:

$4

As % of share price:

3.64% EXTREME UNCERTAINTY

As % of market cap:

2.32% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.17

Revenue 95th %ile:

$20

EPS 75th %ile:

-$0.20

Revenue 75th %ile:

$16

EPS 25th %ile:

-$0.23

Revenue 25th %ile:

$14

EPS 5th %ile:

-$0.26

Revenue 5th %ile:

$11

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

60% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$280

Bid-ask per Share:

$0.03